Moderna Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Moderna (MRNA) Extends Gain After Earnings, Up 6%
February 24, 2022 9:08 AM ESTModerna (NASDAQ: MRNA) Extends Gain After Earnings, Up 6%
Moderna (MRNA) Tops Q4 EPS by $1.39, Announces $3 billion share repurchase plan
February 24, 2022 7:00 AM ESTModerna (NASDAQ: MRNA) reported Q4 EPS of $11.29, $1.39 better than the analyst estimate of $9.90. Revenue for the quarter came in at $7.2 billion versus the consensus estimate of $6.78 billion.
Moderna announces a new $3 billion share repurchase planFor earnings history and earnings-related data on Moderna (MRNA) click here.
... More